As a chronic condition, type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells, so the pancreas produces little to no insulin.
While insulin therapy has been the cornerstone of managing this condition – to help maintain proper blood sugar levels, it’s not a cure and can be complex. The limitations and risks of insulin therapy — ranging from hypoglycemia to the need for constant monitoring — shows why scientists are research more advanced approaches to managing this disease.
At BioXcellerator, we are taking advantage of new research on the use of mesenchymal stem cells (MSCs) to develop stem cell therapy that could reshape the future of diabetes care.
Current State of Type 1 Diabetes Treatments
Traditionally, managing type 1 diabetes involves a careful balance of insulin therapy, diet, and exercise to maintain blood sugar levels within a target range. Despite advances in insulin delivery methods, such as insulin pumps and continuous glucose monitors, patients still face the daily burden of disease management and the long-term risk of complications, including cardiovascular disease, neuropathy, and kidney damage.
The daily realities of disease management weigh heavily on patients because there are many risks of severe long-term complications.
The Pitfalls of Existing Treatments
While current treatments can be effective at managing symptoms, they fall short of addressing the underlying causes of type 1 diabetes.
The autoimmune nature of the disease continues – even with treatment – leading to progressive loss of beta cells and life-long insulin dependency. Furthermore, the risk of severe hypoglycemia and diabetic ketoacidosis remains. This clearly demonstrates why research into more innovative and curative approaches – those that can go beyond symptom management to address the disease’s root causes – is the subject of many research studies.
A New Era Dawns: BioXcellerator Mesenchymal Stem Cell Therapy
BioXcellerator stands at the forefront of medical innovation, working on our own research and collaborating with the global scientific and academic community to harness the potential of using mesenchymal stem cells (MSCs) to treat type 1 diabetes. Our research focuses on a specific source of MSCs, those that come from the Wharton’s jelly from donated umbilical cords.
Ongoing research suggests that mesenchymal stem cells can promote healing in a way that can not only ease symptoms and improve overall health, but may also address the root causes of type 1 diabetes through three key mechanisms:
- Modulating Autoimmune Response: MSC therapy has shown promise in helping to regulate the body’s immune response, reducing the destruction of beta cells. This immunomodulatory effect can slow down, or potentially halt, the progression of type 1 diabetes, preserving the body’s ability to produce insulin.
- Regeneration of Beta Cells: One of the most exciting aspects of stem cell therapy is its potential to promote the regeneration of beta cells that produce insulin. By creating an environment more suitable for cell growth, MSCs may help to restore the insulin-producing capabilities of the pancreas to potentially restore natural insulin production.
- Angiogenesis and Blood Vessel Formation: Improved blood flow and the formation of new blood vessels are critical for the health and function of regenerated beta cells. MSC therapy supports angiogenesis, to help these cells receive the necessary nutrients and oxygen to thrive.
Transforming Lives: Success Stories from BioXcellerator Patients
Our work and reputation is seen in some of the stories patients tell about their treatment experience and results.
One patient treated for Lyme disease, an autoimmune disorder, is David Trowbridge. After researching stem cells he says, “I came across BioXcellerator, it seemed like they were having good results.”
He said that he was impressed with our clinic and staff because “they give you the education of what they are trying to help you with. They take the time to do that, which I really appreciated.”
His treatment demonstrates the potential of MSC therapy to modulate the immune system, and make it possible to help diabetes patients.
Another patient, Kevin Feng, was treated for another autoimmune disorder, Crohn’s disease, which affects the digestive system.
Kevin explained that he looked outside the U.S. for treatment because “the American medical system doesn’t really have any solutions to fix Crohn’s.”
He said that after treatment, “my overall general condition has been completely enhanced.”
“I felt effects starting actually just two weeks in. I noticed my inflammation going down.” Although recovery was gradual, Kevin pointed out, “Within three of four months I was almost close to back to normal.”
Kevin’s treatment may reveal how the regenerative properties of MSCs may have potential to help type 1 diabetes patients.
The Science Behind Our Cells
Research continues but stem cells – especially MSCs – represent a new way to treat patients, an alternative to medications based on advanced research. At BioXcellerator, our physicians treat patients with MSCs for a wide range of diseases, conditions, and injuries.
And we take great care to control the production of cells used for treatment. At our on-site lab, we harvest MSCs from donated umbilical cords and then culture and expand these cells in our own lab to assure that patients receive fresh high-quality cells – our Signature Cells – with the best potential to promote healing.
Learn more about our science and our research organization that now enjoys an enviable global reputation. It’s becoming clearer that stem cell therapy suggests that a new era in the treatment of type 1 diabetes and similar diseases may be dawning.
Connect With Us
To learn more about how BioXcellerator stem cell therapy could revolutionize the treatment of type 1 diabetes, visit our website. Our dedication to advancing stem cell therapy reflects our commitment to offering hope and healing to those suffering from chronic conditions like type 1 diabetes.
In embracing the potential of mesenchymal stem cells, BioXcellerator is not just envisioning a future where diabetes can be managed more effectively; we are actively working to create it.
To learn even more about these treatments and how stem cells can help, schedule a discovery call today with one of our experts.
